| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA444478 | 3 | IC50 | = | 0.006 | uM | ALA5241710 | 8.20 | nM | Homo sapiens | ||
| 2. | ALA444478 | 3 | Activity | = | 60 | % | ALA5140852 | % | Escherichia coli | |||
| 3. | ALA444478 | 3 | IC50 | = | 2.6 | ug ml-1 | ALA5133572 | ug.mL-1 | ||||
| 4. | ALA444478 | 3 | IC50 | = | 0.09 | ug ml-1 | ALA5133571 | ug.mL-1 | ||||
| 5. | ALA444478 | 3 | Ki | = | 0.7 | uM | ALA4428368 | 6.16 | nM | Leishmania amazonensis | ||
| 6. | ALA444478 | 3 | EC50 | = | 19 | uM | ALA4428369 | 4.72 | nM | Leishmania amazonensis | ||
| 7. | ALA444478 | 3 | Activity | 0 | ALA4428370 | Active | Leishmania amazonensis | |||||
| 8. | ALA444478 | 3 | EC50 | = | 14 | uM | ALA4428371 | 4.85 | nM | Leishmania donovani | ||
| 9. | ALA444478 | 3 | HC>=50 | = | 1000 | ug ml-1 | ALA4425008 | ug ml-1 | ||||
| 10. | ALA444478 | 3 | Activity | 0 | ALA4425007 | Non-Toxic | ||||||
| 11. | ALA444478 | 3 | FICI | = | 0.72 | ALA4425006 | Cryptococcus neoformans | |||||
| 12. | ALA444478 | 3 | MIC | = | 62.5 | ug ml-1 | ALA4425005 | ug.mL-1 | Cryptococcus neoformans | |||
| 13. | ALA444478 | 3 | MIC | = | 62.5 | ug ml-1 | ALA4425004 | ug.mL-1 | Cryptococcus neoformans | |||
| 14. | ALA444478 | 3 | MIC | > | 125 | ug ml-1 | ALA4425002 | ug.mL-1 | Candida albicans | |||
| 15. | ALA444478 | 3 | MIC | = | 125 | ug ml-1 | ALA4425003 | ug.mL-1 | Candida parapsilosis | |||
| 16. | ALA444478 | 3 | IC50 | = | 11.3 | uM | ALA4407210 | 4.95 | nM | Ovis aries | ||
| 17. | ALA444478 | 3 | inhibition | = | 0.39 | % | ALA4808150 | % | Homo sapiens | |||
| 18. | ALA444478 | 3 | inhibition | = | -16.78 | % | ALA4808149 | % | Homo sapiens | |||
| 19. | ALA444478 | 3 | Inhibition | = | -2.07 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 20. | ALA444478 | 3 | inhibition | = | -0.17 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 |
The page will load shortly, Thanks for your patience!